Medline Inc. (MDLN)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Front Line Care Revenue	6.51B	6.09B
Front Line Care Revenue Growth	7.00%	4.16%
Surgical Solutions Revenue	6.17B	5.47B
Surgical Solutions Revenue Growth	12.70%	10.95%
Laboratory and Diagnostics Revenue	1.04B	956.00M
Laboratory and Diagnostics Revenue Growth	8.79%	14.22%
Medline Brand Revenue	13.72B	12.52B
Medline Brand Revenue Growth	9.63%	7.77%
Supply Chain Solutions Revenue	14.71B	12.99B
Supply Chain Solutions Revenue Growth	13.24%	11.83%
Revenue (Other)	-	-
Revenue (Total)	28.43B	25.51B
Revenue (Total) Growth	11.47%	9.80%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United Stated Revenue	26.48B	23.75B
United Stated Revenue Growth	11.51%	8.93%
International Revenue	1.95B	1.76B
International Revenue Growth	10.97%	22.99%
Revenue (Other)	-	-
Revenue (Total)	28.43B	25.51B
Revenue (Total) Growth	11.47%	9.80%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Medline Brand Adjusted EBITDA	3.33B	3.27B
Medline Brand Adjusted EBITDA Growth	1.99%	20.89%
Supply Chain Solutions Adjusted EBITDA	805.00M	647.00M
Supply Chain Solutions Adjusted EBITDA Growth	24.42%	31.77%
Operating Income (Other)	-1.93B	-1.77B
Operating Income (Total)	2.21B	2.15B
Operating Income (Total) Growth	3.08%	71.68%

Updated Feb 25, 2026. Data Source: Fiscal.ai.